Mert Ali Dölek

Dr. Mert Ali Dölek

orcid

Research Focus & Metrics

Academic Career Length

4Years (2023-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
31 August 2025 in Journal of Trends in Medical Investigation
Verified
Journal Article
Open access
PDF file
EÇEkrem Çakar
Ekrem Çakar
OKOnur Olgaç Karagülle
Onur Olgaç Karagülle
SKSündüz Zeynep Küçüksümer
Sündüz Zeynep Küçüksümer
MDMert Ali Dölek
Mert Ali Dölek
BGBünyamin Gürbulak
Bünyamin Gürbulak
MSMert Mahsuni Sevinc
Mert Mahsuni Sevinc
Aim: Rare conditions causing biliary obstruction, such as Fasciola hepatica infestation, SUMP syndrome, Lemmel syndrome, Wirsung duct stones, Mirizzi syndrome, and surgical clip migration, are infrequently encountered during ERCP. This study aims to analyze the clinical and demographic characteristics, diagnostic challenges, and management of these uncommon conditions in a single-center cohort. Method: This retrospective study included 6,700 patients aged 18 and older who underwent ERCP between 2000 and 2024. Patients with common bile duct stones, benign fibrosis, or malignancy were excluded, resulting in 28 cases with rare biliary pathologies. Data on clinical presentations, imaging findings, and treatment outcomes were analyzed. Results: Among the 6,700 patients, the incidence of Fasciola hepatica infestation was 0.06% (n = 4), SUMP syndrome 0.75% (n = 5), Lemmel syndrome 0.06% (n = 4), Wirsung duct stones 0.044% (n = 3), Mirizzi syndrome 0.15% (n = 10), and surgical clip migration 0.03% (n = 2). Cholangitis was the most common clinical presentation across most conditions, with notable differences in total bilirubin levels, common bile duct diameters, and associated imaging findings. All cases were successfully managed with ERCP, and no complications were observed. Conclusion: This study underscores the importance of recognizing rare biliary pathologies in patients presenting with atypical symptoms or a history of biliary surgery. Although these conditions represent a small percentage of patients undergoing ERCP, their timely diagnosis and management are crucial to preventing complications. For this reason, we are presenting these rare conditions collectively in the literature for the benefit of endoscopists.

1 August 2023 in Istanbul Medical Journal
Verified
Journal Article
Closed access
ATAbdurrahman Tünay
Abdurrahman Tünay
MGMert Guler
Mert Guler
MDMert Ali Dölek
Mert Ali Dölek
SDSelim Dogan
Selim Dogan
ÖAÖzlem Ateşal
Özlem Ateşal
MTMehmet Toptaş
Mehmet Toptaş

18 May 2026 in Biomedicines
Verified
Journal Article
Open access
PDF file
UIUfuk Oguz Idiz
Ufuk Oguz Idiz
IMIlhan nahit Mutlu
Ilhan nahit Mutlu
YBYucel Barut
Yucel Barut
EKEyüp Kaya
Eyüp Kaya
AFAysegul Ferlengez
Aysegul Ferlengez
MSMert Mahsuni Sevinc
Mert Mahsuni Sevinc
Background and Objectives: Malignant ascites reflects the tumor microenvironment and provides valuable insights into peritoneal metastasis. This study aimed to assess soluble immune system-related molecules in the ascites fluid of advanced gastrointestinal cancer patients with peritoneal carcinomatosis and to explore potential therapeutic opportunities. Methods: This multicenter prospective cohort study included 48 patients with gastrointestinal adenocarcinoma (17 colorectal, 16 gastric, and 15 pancreatic) with malignant ascites and 15 patients for comparison who required benign ascites drainage for advanced heart failure. Blood samples for routine parameters and ascites fluid for cytokine and soluble immune checkpoint analysis were collected. Parameters were compared between cancer patients and the comparison group, across cancer subgroups, and in correlation with survival. Results: The mean age of participants was 60.2 ± 14.9 years, with a female-to-male ratio of 11:20. The median survival of cancer patients was 84.0 days. Compared with heart failure-associated transudative ascites, malignant ascites demonstrated higher levels of TNF-α, IL-6, IL-10, IL-12p70, IL-18, IL-23, s4-1BB, and TGF-β1, while albumin levels were lower. Significant intergroup differences were observed in TNF-α, IL-6, IL-8, IL-10, IL-12p70, IL-23, 4-1BB, TGF-β1, and PD-L1 levels. In exploratory multivariable analysis, IL-10 and soluble 4-1BB emerged as potential predictors of shorter survival, although these findings require validation in larger cohorts. Survival was negatively correlated with PD-L1, TNF-α, IL-6, and IL-10 in colorectal cancer; 4-1BB, TGF-β1, IL-8, and IL-10 in gastric cancer; and TGF-β1, IL-6, and IL-10 in pancreatic cancer. Conclusions: These exploratory findings indicate that the immunosuppressive milieu in malignant ascites in gastrointestinal cancers may be mediated by cancer subtype-specific pathways, warranting further mechanistic and translational investigation.